Bombardieri E - Search Results

1

Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma.

Audisio RA, Veronesi P, Maisonneuve P, Chiappa A, Andreoni B, Bombardieri E, Geraghty JG. Audisio RA, et al. Among authors: bombardieri e. Surg Oncol. 1996 Apr;5(2):49-63. doi: 10.1016/s0960-7404(96)80001-6. Surg Oncol. 1996. PMID: 8853239 Review.

2

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

3

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

Seregni E, Ferrari L, Martinetti A, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Semin Surg Oncol. 2001 Mar;20(2):147-66. doi: 10.1002/ssu.1028. Semin Surg Oncol. 2001. PMID: 11398208 Review.

4

Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.

Saccani Jotti G, Fontanesi M, Bombardieri E, Gabrielli M, Veronesi P, Bianchi M, Becchi G, Bogni A, Tardini A. Saccani Jotti G, et al. Among authors: bombardieri e. Int J Biol Markers. 1992 Jan-Mar;7(1):35-42. Int J Biol Markers. 1992. PMID: 1349907

5

Mucinous markers in breast cancer.

Seregni E, Botti C, Massaron S, Martinetti A, Ferrari L, Molteni SN, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Tumori. 1997 Mar-Apr;83(2):550-1. doi: 10.1177/030089169708300214. Tumori. 1997. PMID: 9226018 Review. No abstract available.

6

Potential circulating markers for the management of kidney cancer (Review).

Botti C, Seregni E, Mattioli S, Massaron S, Bonanate A, Cantarella D, Bombardieri E. Botti C, et al. Among authors: bombardieri e. Int J Oncol. 1997 Jan;10(1):147-57. doi: 10.3892/ijo.10.1.147. Int J Oncol. 1997. PMID: 21533358

7

Diagnostic procedures in the follow-up of patients affected by MEN type 2.

Seregni E, Pallotti F, Mattavelli F, Ferrari L, Martinetti A, Aliberti G, Villano C, Castellani MR, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Tumori. 2003 Sep-Oct;89(5):563-5. doi: 10.1177/030089160308900524. Tumori. 2003. PMID: 14870788 Review.

8

Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.

Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL. Crippa F, et al. Among authors: bombardieri e. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):52-5. J Nucl Biol Med (1991). 1992. PMID: 1450226

9

Mucinic tumor markers recognized by monoclonal antibodies.

Seregni E, Bombardieri E, Maffioli L, Buraggi GL. Seregni E, et al. Among authors: bombardieri e. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):314-20. J Nucl Med Allied Sci. 1990. PMID: 2090797 Review. No abstract available.

10

Circulating tumor markers in breast cancer (review).

Jotti GS, Bombardieri E. Jotti GS, et al. Among authors: bombardieri e. Anticancer Res. 1990 Jan-Feb;10(1):253-8. Anticancer Res. 1990. PMID: 2185687 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters